| The tumor microenvironment innately modulates cancer progression DC Hinshaw, LA Shevde Cancer research 79 (18), 4557-4566, 2019 | 2165 | 2019 |
| The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis AI Riker, SA Enkemann, O Fodstad, S Liu, S Ren, C Morris, Y Xi, P Howell, ... BMC medical genomics 1, 1-16, 2008 | 579 | 2008 |
| Role of osteopontin in the pathophysiology of cancer LA Shevde, RS Samant Matrix Biology 37, 131-141, 2014 | 272 | 2014 |
| Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment A Hanna, LA Shevde Molecular cancer 15, 1-14, 2016 | 232 | 2016 |
| Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription WJ Meehan, RS Samant, JE Hopper, MJ Carrozza, LA Shevde, ... Journal of Biological Chemistry 279 (2), 1562-1569, 2004 | 227 | 2004 |
| Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1 LA Shevde, RS Samant, SF Goldberg, T Sikaneta, A Alessandrini, ... Experimental cell research 273 (2), 229-239, 2002 | 225 | 2002 |
| Osteopontin: an effector and an effect of tumor metastasis LA Shevde, S Das, DW Clark, RS Samant Current molecular medicine 10 (1), 71-81, 2010 | 215 | 2010 |
| Metastasis suppressor pathways—an evolving paradigm LA Shevde, DR Welch Cancer letters 198 (1), 1-20, 2003 | 211 | 2003 |
| CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival E Meng, B Long, P Sullivan, S McClellan, MA Finan, E Reed, L Shevde, ... Clinical & experimental metastasis 29, 939-948, 2012 | 200 | 2012 |
| A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis JF Harms, DR Welch, RS Samant, LA Shevde, ME Miele, GR Babu, ... Clinical & experimental metastasis 21, 119-128, 2004 | 164 | 2004 |
| Recent advances in anti-angiogenic therapy of cancer RS Samant, LA Shevde Oncotarget 2 (3), 122, 2011 | 163 | 2011 |
| ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling E Meng, A Mitra, K Tripathi, MA Finan, J Scalici, S McClellan, LM da Silva, ... PloS one 9 (9), e107142, 2014 | 160 | 2014 |
| Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation RS Samant, DW Clark, RA Fillmore, M Cicek, BJ Metge, ... Molecular cancer 6, 1-9, 2007 | 159 | 2007 |
| Analysis of mechanisms underlying BRMS1 suppression of metastasis RS Samant, MJ Seraj, MM Saunders, TS Sakamaki, LA Shevde, JF Harms, ... Clinical & experimental metastasis 18, 683-693, 2000 | 157 | 2000 |
| Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer F Mbeunkui, BJ Metge, LA Shevde, LK Pannell Journal of proteome research 6 (8), 2993-3002, 2007 | 142 | 2007 |
| The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin S Das, LG Harris, BJ Metge, S Liu, AI Riker, RS Samant, LA Shevde Journal of Biological Chemistry 284 (34), 22888-22897, 2009 | 134 | 2009 |
| Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435 LA Shevde, RS Samant, JC Paik, BJ Metge, AF Chambers, G Casey, ... Clinical & experimental metastasis 23, 123-133, 2006 | 133 | 2006 |
| Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61 LG Harris, LK Pannell, S Singh, RS Samant, LA Shevde Oncogene 31 (28), 3370-3380, 2012 | 129 | 2012 |
| Emerging role of nuclear protein 1 (NUPR1) in cancer biology UR Chowdhury, RS Samant, O Fodstad, LA Shevde Cancer and Metastasis Reviews 28, 225-232, 2009 | 128 | 2009 |
| Dickkopf1: a tumor suppressor or metastasis promoter? ME Menezes, DJ Devine, LA Shevde, RS Samant International journal of cancer 130 (7), 1477-1483, 2012 | 126 | 2012 |
